Management Iii Llc Venrock is 10% at Vitae Pharmaceuticals, Inc (VTAE). They have made 1 open-market trade across 1 company since 2014, most recently 2014-09-29.
CIK 0001239247
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6.2M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VTAE | 1,883,372 | $39.6M |
Shares reported on the most recent Form 4, priced at the 2014-10-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTAE | BUY | 2014-09-29 | 2014-10-01 | $8.00 | $6.2M | -36.0% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.